Clinical Trial Update: Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating hydroxychloroquine in adults with solid tumors undergoing radiation therapy for bone metastases was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Bone Metastases, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: TERMINATED